# Xenopus laevis as an infection model for human pathogenic bacteria

**Authors:** Ayano Kuriu, Kazuya Ishikawa, Kohsuke Tsuchiya, Kazuyuki Furuta, Chikara Kaito

PMC · DOI: 10.1128/iai.00126-25 · Infection and Immunity · 2025-05-01

## TL;DR

Juvenile Xenopus frogs can be used as a model to study human pathogenic bacteria and test antimicrobial treatments.

## Contribution

This study demonstrates that Xenopus laevis is a viable model for evaluating virulence and antimicrobial efficacy of human pathogenic bacteria.

## Key findings

- Xenopus frogs die when injected with pathogenic bacteria like Staphylococcus aureus and Pseudomonas aeruginosa.
- Antibiotics can reduce mortality caused by these bacteria in Xenopus frogs.
- Virulence gene-deleted bacterial strains show reduced pathogenicity in Xenopus frogs.

## Abstract

Animal infection models are essential for understanding bacterial pathogenicity and corresponding host immune responses. In this study, we investigated whether juvenile Xenopus laevis could be used as an infection model for human pathogenic bacteria. Xenopus frogs succumbed to intraperitoneal injection containing the human pathogenic bacteria Staphylococcus aureus, Pseudomonas aeruginosa, and Listeria monocytogenes. In contrast, non-pathogenic bacteria Bacillus subtilis and Escherichia coli did not induce mortality in Xenopus frogs. The administration of appropriate antibiotics suppressed mortality caused by S. aureus and P. aeruginosa. Strains lacking the agr locus, cvfA (rny) gene, or hemolysin genes in S. aureus, LIPI-1-deleted mutant of L. monocytogenes, which attenuate virulence within mammals, exhibited reduced virulence in Xenopus frogs compared with their respective wild-type counterparts. Bacterial distribution analysis revealed that S. aureus persisted in the blood, liver, heart, and muscles of Xenopus frogs until death. These results suggested that intraperitoneal injection of human pathogenic bacteria induces sepsis-like symptoms in Xenopus frogs, supporting their use as a valuable animal model for evaluating antimicrobial efficacy and identifying virulence genes in various human pathogenic bacteria.

## Linked entities

- **Genes:** AGR (agouti related neuropeptide) [NCBI Gene 105491420], rny (endoribonuclease Y) [NCBI Gene 939680], LOC105265975 (lipase member I) [NCBI Gene 105265975], LOC106077773 (uncharacterized LOC106077773) [NCBI Gene 106077773]
- **Species:** Xenopus laevis (taxon 8355), Staphylococcus aureus (taxon 1280), Pseudomonas aeruginosa (taxon 287), Listeria monocytogenes (taxon 1639), Bacillus subtilis (taxon 1423), Escherichia coli (taxon 562)

## Full-text entities

- **Diseases:** sepsis (MESH:D018805), infection (MESH:D007239)
- **Species:** Homo sapiens (human, species) [taxon 9606], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Bacillus subtilis (species) [taxon 1423], Pseudomonas aeruginosa (species) [taxon 287], Xenopus laevis (African clawed frog, species) [taxon 8355], Listeria monocytogenes (species) [taxon 1639], Staphylococcus aureus (species) [taxon 1280], Escherichia coli (E. coli, species) [taxon 562]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12150759/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12150759/full.md

## References

83 references — full list in the complete paper: https://tomesphere.com/paper/PMC12150759/full.md

---
Source: https://tomesphere.com/paper/PMC12150759